Serum chromogranin-A-based prognosis in metastatic castration-resistant prostate cancer-Reference-Cited by-同舟云学术

Serum chromogranin-A-based prognosis in metastatic castration-resistant prostate cancer

Published:2018-06-01 Issue:3 Volume:21 Page:431-437
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Giridhar Karthik V.^ORCID,Sanhueza Cristobal,Hillman David W,Alkhateeb Hassan,Carlson Rachel,Tan Winston,Costello Brian A.,Quevedo Fernando,Pagliaro Lance,Kohli Manish

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

http://www.nature.com/articles/s41391-018-0046-9.pdf

Reference24 articles.

1. Wang HT, Yao YH, Li BG, Tang Y, Chang JW, Zhang J. Neuroendocrine Prostate Cancer (NEPC) progressing from conventional prostatic adenocarcinoma: factors associated with time to development of NEPC and survival from NEPC diagnosis-a systematic review and pooled analysis. J Clin Oncol. 2014;32:3383–90.

2. Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM, et al. Integrative clinical genomics of advanced prostate cancer. Cell. 2015;161:1215–28.

3. Jiborn T, Bjartell A, Abrahamsson P-A. Neuroendocrine differentiation in prostatic carcinoma during hormonal treatment. Urology. 1998;51:585–9.

4. Hirano D, Okada Y, Minei S, Takimoto Y, Nemoto N. Neuroendocrine differentiation in hormone refractory prostate cancer following androgen deprivation therapy. Eur Urol. 2004;45:586–92.

5. Beltran H, Rickman DS, Park K, Chae SS, Sboner A, MacDonald TY, et al. Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets. Cancer Discov. 2011;1:487–95.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular biomarkers in prostate cancer tumorigenesis and clinical relevance;Critical Reviews in Oncology/Hematology;2024-02

2. Dual-signal electrochemical immunosensor based on the oxidation and oxygen evolution signals of CoTe2@CeO2 nanocomposites: Application for prostate-specific antigen detection;Sensors and Actuators B: Chemical;2023-10

3. Association between concomitant proton pump inhibitor use and survival of patients with metastatic prostate cancer receiving abiraterone acetate: a post-hoc analysis of pooled data from three randomized controlled trials;Prostate Cancer and Prostatic Diseases;2023-07-18

4. Prognostic Significance of Chromogranin A Expression in the Initial and Second Biopsies in Metastatic Prostate Cancer;Journal of Clinical Medicine;2023-05-09

5. Association between concomitant proton pump inhibitor use and survival of patients with metastatic prostate cancer receiving abiraterone acetate: a post-hoc analysis of pooled data from three randomized controlled trials;2023-04-25